BEST UNLIMITED TURBO LONG CERTIFICATE - REGENERON PHARMACEUTICALS Share Price

Certificat

GY96S

DE000SD3LYL2

Market Closed - Euronext Paris 11:33:06 08/05/2024 am IST
21.97 EUR +1.86% Intraday chart for BEST UNLIMITED TURBO LONG CERTIFICATE - REGENERON PHARMACEUTICALS
Current month+16.42%
1 month+3.51%
Date Price Change Volume
08/24/08 21.97 +1.86% 1
07/24/07 21.57 +2.25% 38
06/24/06 21.09 +2.22% 42
03/24/03 20.63 +0.92% 42
02/24/02 20.45 +10.37% 51

Real-time Euronext Paris

Last update May 08, 2024 at 11:33 am IST

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying REGENERON PHARMACEUTICALS, INC.
IssuerLogo Issuer Société Générale Société Générale
GY96S
ISINDE000SD3LYL2
Date issued 05/02/2021
Strike 507.8 $
Maturity Unlimited
Parity 20 : 1
Emission price 4.15
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 23.43
Lowest since issue 2.185

Company Profile

Regeneron Pharmaceuticals, Inc. specializes in research, development, producing, and selling drugs used in treating ophthalmologic and inflammatory diseases and cancers. Net sales break down by type of revenue as follows: - revenues from product sales (56.6%); - revenues from collaboration agreements (40.4%): collaboration with Sanofi (58.1% of revenues), Bayer (29.1%) and Roche (12.8%); - other (3%): primarily revenues from sales of technology licenses and subcontracted research services. At the end of 2022, the group had a portfolio of approximately 35 products in clinical development.
Sector
-
More about the company

Ratings for Regeneron Pharmaceuticals, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Regeneron Pharmaceuticals, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
970 USD
Average target price
1,034 USD
Spread / Average Target
+6.65%
Consensus
  1. Stock Market
  2. Certificates
  3. GY96S Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW